October 20, 2020
Business News

AstraZeneca coronavirus vaccine trial remains on hold in the U.S., HHS chief Azar says – CNBC

AstraZeneca’s late-stage coronavirus vaccine trial in the U.S. remains on hold as federal investigators seek “answers to important questions” over its safety for patients, Health and Human Services Secretary Alex Azar told CNBC on Wednesday.  
Global clinical trials for AstraZeneca’s Covid-19 vaccine, called AZD1222, were placed on hold Sept. 6 after one of the participants in the U.K. reported a serious adverse reaction. Following an investigation, AstraZeneca said on Sept. 12 that it had resu…

Click here to view the original article.

Related Posts

You might also like ...

MerchantE Joins NetSuite Now On Air Virtual Conference Lineup
CORRECTING and REPLACING MyVest and Facet Wealth Collaborate on Employee Financial Wellness Program
AON Splash Image
Shuman, Glenn & Stecker Investigates Ryder System, Inc.